Itcould be assumed that in chronic relapsing brucellosis patients prior exposuresto Brucella LPS, as a result of relapses during the chronic stage, leads to “crosstolerance” (low percentage of CD4+/CD28+ T-cells) to further in vitro E.coli LPS challenge. This evidence concerns the gene CD28 and brucellosis.